Of note, they observed heterogeneous responses with 5 of 12 models showing an immune-dependent suppression of metastasis, while another 3 models responded to anti-TGFβ therapy with an undesirable stimulation of metastasis, which was immune-independent and targeted the tumor cell compartment. This evidence concerns the gene TGFB1 and neoplasm.